Activating SRC mutation in a subset of advanced human colon cancers

R B Irby1, W Mao, D Coppola

  • 1Department of Surgery, H. Lee Moffitt Cancer Center & Research Institute, University of South Florida College of Medicine, Tampa 33612, USA.

Nature Genetics
|February 13, 1999
PubMed

Insights

Activating mutations in the SRC gene are found in advanced colon cancer, promoting tumor growth and metastasis. This discovery provides genetic evidence for SRC

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Rous sarcoma virus (RSV) discovery led to cellular Src (c-Src), a non-receptor tyrosine kinase implicated in human cancers.
  • c-Src is highly activated in colon cancers, especially those with liver metastasis.
  • c-Src regulation involves carboxy-terminal tyrosine phosphorylation (Tyr 530), with implications for activating mutations.

Purpose of the Study:

  • To identify and characterize activating mutations in the SRC gene in advanced human colon cancer.
  • To investigate the role of these mutations in tumor progression, metastasis, and transformation.

Main Methods:

  • Genetic analysis to identify mutations in the SRC gene in colon cancer patients.
  • Functional assays to assess the kinase activity, transforming potential, tumorigenicity, and metastatic ability of the identified SRC mutation.

Main Results:

  • A truncating mutation in SRC at codon 531 was identified in 12% of advanced colon cancer cases.
  • This SRC mutation was demonstrated to be activating, transforming, tumorigenic, and to promote metastasis.

Conclusions:

  • Activating SRC mutations, specifically the codon 531 truncation, play a role in the malignant progression of human colon cancer.
  • This provides the first genetic evidence linking activating SRC mutations to colon cancer metastasis.

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...